Clostridium botulinum types C and D and the closely related Clostridium novyi

Reviews and Research in Medical Microbiology

Volumn 13, Issue 2, 2002, Pages 75-90

  Hunter, Leonie C ^a   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Botulism; Clostridium botulinum; Clostridium novyi; Equine grass sickness; Group III clostridia; Injecting drug abuse; Neurotoxin; Toxicoinfection

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; BOTULINUM TOXIN C; BOTULINUM TOXIN C 2; BOTULINUM TOXIN C1; BOTULINUM TOXIN D; BOTULINUM TOXIN E; BOTULINUM TOXIN F; BOTULINUM TOXIN G; EXOENZYME C3; UNCLASSIFIED DRUG;

ADENOSINE DIPHOSPHATE RIBOSYLATION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BOTULISM; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM NOVYI; GANGRENE; HUMAN; INFECTION RISK; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SPECIES DIFFERENTIATION; TOXIN SYNTHESIS;

CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM NOVYI;

EID: 0036289567     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013542-200204000-00004     Document Type: Article

References (130)

1. Bacterial sources of clostridial neurotoxins
2. Examination of faeces and serum for diagnosis of infant botulism: Experience in 336 patients
3. Phylogeny and taxonomy of the food-borne pathogen Clostridium botulinum and its neurotoxins
4. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism
5. Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism
6. Characterisation of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the faeces of an infant with type E botulism
7. Variation among strains of Clostridium botulinum and related clostridia
8. Clostridium Prazmowski 1880, 23
9. Genetic interrelationships of proteolytic Clostridium botulinum types A, B and F and other members of the Clostridium botulinum complex as revealed by small-subunit rRNA gene sequences
10. Evidence for plasmid-mediated toxin and bacteriocin production in Clostridium botulinum type G
11. Plasmid localisation of a type E botulinal neurotoxin gene homologue in toxigenic Clostridium butyricum strains, and absence of this gene in non-toxigenic C. butyricum strains
12. Bacteriophage and the toxigenicity of Clostridium botulinum type C
13. Bacteriophage and the toxigenicity of Clostridium botulinum type D
14. Demonstration of the common antigens of Clostridium botulinum, C. sporogenes and C. novyi by an enzyme-linked immunosorbent assay and electroblot transfer
15. Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay
16. Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage
17. Sporulation and C2 toxin production by Clostridium botulinum type C strains producing no C1 toxin
18. C2 toxicity in extract of Clostridium botulinum type C spores
19. Relationship of bacteriophages to toxin and haemagglutinin production by Clostridium botulinum types C and D and its significance in avian botulism outbreaks
20. Preliminary note on a toxin-producing anaerobe isolated from the larvae of Lucilia caesar
21. Bulbar paralysis in cattle due to the action of a toxigenic bacillus with a discussion on the relation of the condition to forage poisoning
22. Cultural study of an international collection of Clostridium botulinum and parabotulinum
23. C. botulinum type D sp nov.
24. The toxic antigenic factors produced by Clostridium botulinum types C and D
25. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains
26. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains
27. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum
28. Analysis of antigenicity of Clostridium botulinum type C1 and D toxins by polyclonal and monoclonal antibodies
29. Biological and biophysical characteristics of phages isolated from Clostridium botulinum type C and D strains, and physicochemical properties of the phage DNAs
30. Molecular diversity of neurotoxins from Clostridium botulinum type D strains
31. Isolation and characterisation of converting and non-converting phages harbored in the strains of Clostridium botulinum types C and D isolated in Japan
32. Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenised organisms
33. Botulinal neurotoxin C1 complex genes, clostridial neurotoxin homology and genetic transfer in Clostridium botulinum
34. Clostridium novyi
35. Relationship of bacteriophages to alpha toxin producion in Clostridium novyi types A and B
36. Electrophoretic study of Clostridium species
37. Taxonomic relationships among Clostridium novyi types A and B, Clostridium haemolyticum and Clostridium botulinum type C
38. Bacteriophages and plasmids of Clostridium botulinum and Clostridium tetani and their relationship to production of toxins
39. Conversion to toxigenicity in Clostridium botulinum type C
40. Phage conversion of toxigenicity on Clostridium botulinum types C and D
41. Antigenicity of converting phages obtained from Clostridium botulinum types C and D
42. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages
43. Conversion of Clostridium novyi type D (C. haemolyticum) to alpha toxin production by phages of C. novyi type A
44. Toxigenic clostridia
45. The toxins of Clostridium oedematiens (Cl. novyi)
46. Phylogenetic basis for a taxonomic dissection of the genus Clostridium
47. Crystal structure of botulinum neurotoxin type A and implications for toxicity
48. Tetanus and botulism neurotoxins: A new group of zinc proteases
49. Mechanism of action of tetanus and botulinum neurotoxins
50. Bacterial protein toxins penetrate cells via a four-step mechanism
51. Neurotoxins affecting neuroexocytosis
52. Oral toxicities of Clostridium botulinum type C and D toxins of different molecular sizes
53. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in bonding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin
54. Characterisation of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one sub-component of haemagglutinin (HA1)
55. Association between the cell-wall peptidoglycan and the progenitor toxin of Clostridium botulinum type C
56. Cell-bound toxin of Clostridium botulinum type C and its pathogenic significance
57. Binding and transcytosis of botulinum neurotoxin by polarised human colon carcinoma cells
58. Binding of Clostridium botulinum type C neurotoxin to different neuroblastoma cell lines
59. Binding and cytotoxic effects of Clostridium botulinum type A, C1 and E toxins in primary neuron cultures from foetal mouse brains
60. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes
61. Inhibitory effect of ganglioside GT1b on activities of Clostridium botulinum toxins
62. 125I-labelled botulinum neurotoxins with nerve terminals. II Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis
63. Molecular biology of clostridial neurotoxins
64. Ion-conducting channels produced by botulinum toxin in planar lipid membranes
65. The N-terminal half of the heavy chain of botulinum type A neurotoxin forms channels in planar phospholipid bilayers
66. Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin
67. Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP/synaptobrevin
68. Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D and E
69. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
70. Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1/syntaxin
71. Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins
72. Clostridial neurotoxins and substrate proteolysis in intact neurons. Botulinum neurotoxin acts on synaptosomal-associated protein of s5kDa
73. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: Correlation with its blockade of catecholamine release
74. Common and distinct fusion proteins in axonal growth and transmitter release
75. Novel targets and catalytic activities of bacterial protein toxins
76. SNAP receptors implicated in vesicle targeting and fusion
77. Synaptic vesicle membrane fusion complex: Action of clostridial neurotoxins on assembly
78. SNARE motif and neurotoxins
79. Botulinum neurotoxin C acts on synataxin and SNAP-25 and its cytotoxic to neurons
80. Syntaxin and 25kDA Synaptosomal-associated protein: Differential effects of botulinum neurotoxins C1 and A on neuronal survival
81. Growth cone collapse and inhibition of neurite growth by botulinum neurotoxin C1:A t-SNARE is involved in axonal growth
82. The effects of purified botulinum neurotoxin type A on cholinergic, adrenergic and non-adrenergic, atropine-resistant autonomic neuromuscular transmission
83. Botulinum A toxin inhibits the release of noradrenaline, acetylcholine, γ-aminobutyric acid and glycine from particles of rat brain and spinal cord
84. Clostridium botulinum neurotoxin
85. Botulinum neurotoxin serotype C: A novel effective botulinum toxin therapy in humans
86. Clostridium botulinum
87. The global importance of type C botulism in wild birds
88. The ecology and natural history of Clostridium botulinum
89. In vitro characterisation of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches
90. The scope of the avian botulism problem
91. Type C botulism: The agent, host susceptibility and predisposing factors
92. Botulism
93. The changing epidemiology of adult botulism in the United States
94. Laboratory investigation of botulism in wild birds
95. Persistence of Clostridium botulinum type C toxin in blowfly (Calliphoridae) larvae as a possible cause of avian botulism in spring
96. A comparison of the pharmacological properties of Clostridium botulinum type C1 and C2 toxins
97. The production of Clostridium botulinum type A, B and D toxin in rotting carcasses
98. The production of Clostridium botulinum toxin in mammalian, avian and piscine carrion
99. Landfill sites, botulism and gulls
100. Botulism, type C. Experimental and field cases in horses
101. Infant botulism: Identification of Clostridium botulinum and its toxin in faeces
102. Honey and other environmental risk factors for infant botulism
103. Botulism in an adult associated with food-borne intestinal infection with Clostridium botulinum
104. Animal models of botulism and tetanus
105. Laboratory procedures for cases of suspected infant botulism
106. Laboratory findings in four cases of adult botulism suggest colonisation of the intestinal tract
107. Toxicoinfectious botulism in foals and adult horses
108. Experimentally induced toxicoinfectious botulism in horses and foals
109. Botulism outbreak associated with poultry litter consumption in three Brazilian cattle herds
110. A major outbreak of botulism in cattle being fed ensiled poultry litter
111. The association of Clostridium botulinum type C with equine grass sickness: A toxicoinfection?
112. Systemic antibodies to Clostridium botulinum type C: Do they protect horses from grass sickness (dysautonomia)?
113. Grass Sickness in horses
114. Wound botulism in the UK
115. Purification and characterization of two components of botulinum C2 toxin
116. Vascular permeability activity of botulinum C2 toxin elicited by cooperation of two dissimilar protein components
117. Lethal and vascular permeability activities of botulinum C2 toxin induced by separate injections of two components
118. Response of mouse intestinal loop to botulinum C2 toxin: Enterotoxic activity induced by cooperation of nonlinked protein components
119. Histopathological effect of botulinum C2 toxin on mouse intestines
120. ADP-ribosylation of actin isoforms by C. botulinum C2 toxin and C. perfringens iota toxin
121. Inhibition of the contraction of the isolated longitudinal muscle of the guinea-pig ileum by botulinum Cs toxin: Evidence for a role of G/F actin transition in smooth muscle transaction
122. Clostridial actin-ADP-ribosylating toxins
123. 2- production and secretion but inhibits migration of activated human neutrophils
124. ADP-ribosylation of actin by clostridial toxins
125. Clostridium botulinum type-C intoxication associated with consumption of processed alfafa hay cubes in horses
126. Molecular structure and biological activities of Clostridium botulinum C2 toxin
127. Rho protein regulates tight junctions and perijunctional actin organisation in polarised epithelia
128. The histotoxic clostridial infections of man
129. The action of the lethal toxins of gas gangrene clostridia on capillary permeability
130. Structure and function of Clostridium botulinum toxins